Impact of migrancy on cancer clinical trial participation: Factors associated with approach and consent in Australian-born versus migrant groups.
Bee Teng LimPhyllis ButowMing Lo SzeAfaf GirgisMichael JeffordDavid GoldsteinDaniel CostaPublished in: Asia-Pacific journal of clinical oncology (2020)
Our findings identified that barriers to migrants' self-reported participation in clinical trials include perceived lack of understanding of the health system and low English proficiency. Strategies that address these barriers are needed to increase migrant patients' participation in cancer clinical trials.
Keyphrases
- clinical trial
- physical activity
- papillary thyroid
- end stage renal disease
- phase ii
- newly diagnosed
- ejection fraction
- chronic kidney disease
- double blind
- open label
- depressive symptoms
- peritoneal dialysis
- mental health
- study protocol
- phase iii
- childhood cancer
- prognostic factors
- patient reported outcomes
- randomized controlled trial
- preterm infants
- gestational age
- young adults